Bruker Corporation
BRKR
อันดับในหุ้น
#2333
Bruker Corporation stands as a prominent global developer, manufacturer, and... Bruker Corporation stands as a prominent global developer, manufacturer, and distributor of cutting-edge scientific instruments, alongside comprehensive analytical and diagnostic solutions. Its operations are structured across three distinct segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies. The company's extensive portfolio for life sciences encompasses a variety of advanced tools, including single and multi-modality systems, sophisticated mass spectrometry platforms, and critical diagnostic solutions. These diagnostics feature the acclaimed MALDI Biotyper for swift pathogen identification, various molecular diagnostic kits (such as genotype and fluorotype offerings), DNA test strips, and fluorescence-based polymerase chain reaction (PCR) technology, notably including SARS-CoV-2 testing solutions for COVID-19 diagnosis and Fluorotyper-SARS-CoV-2 plus kits. Beyond life science, Bruker delivers a wide array of specialized instruments for research, analysis, and process control. This includes portable analytical and bioanalytical detection systems, a full range of X-ray instruments (from analytical tools for electron microscopes to handheld, portable, and mobile X-ray fluorescence spectrometry devices), and sophisticated atomic force microscopy (AFM) instrumentation for non-contact nanometer resolution topography. Furthermore, it supplies automated X-ray metrology, automated AFM defect-detection, and equipment for photomask repair and cleaning. The company also excels in advanced optical fluorescence microscopy and provides critical products and services supporting multi-omics research for drug and biomarker discovery. Within its energy sector, Bruker is a key provider of superconducting materials, particularly metallic low-temperature superconductors, and develops complex tools and devices utilizing these materials, alongside other high-technology tools like synchrotron and beamline instrumentation. Reflecting its commitment to innovation, Bruker Corporation collaborates with Newomics Inc. on an LC-MS platform specifically tailored for drug discovery applications. Established in 1991, the corporation maintains its headquarters in Billerica, Massachusetts.
ราคาหุ้น
$55.38
มูลค่าตลาด
$8.44B
การเปลี่ยนแปลง (1 วัน)
1.05%
การเปลี่ยนแปลง (1 ปี)
49.74%
ประเทศ
US
ซื้อขาย Bruker Corporation (BRKR)
หมวดหมู่
Healthcare
รายได้ของ Bruker Corporation (BRKR)
รายได้ใน Jun 2026 TTM: $-28.10M
ตามรายงานทางการเงินล่าสุดของ Bruker Corporation กำไรปัจจุบันของบริษัทคือ $-28.10M ในปี 2024 บริษัทมีกำไร $205.20M ซึ่ง น้อยกว่ารายได้ในปี กำไรในปี 2023 ที่อยู่ที่ $546.20M กำไรที่แสดงในหน้านี้คือกำไรก่อนหักดอกเบี้ยและภาษี หรือที่เรียกว่า EBIT
ประวัติรายได้ของ Bruker Corporation ตั้งแต่ 2000 ถึง 2026
รายได้ ณ สิ้นปีแต่ละปี
| ปี | รายได้ | เปลี่ยน |
|---|---|---|
| 2026 (TTM) | $-28.10M | -195.90% |
| 2025 | $29.30M | -85.72% |
| 2024 | $205.20M | -62.43% |
| 2023 | $546.20M | 31.65% |
| 2022 | $414.90M | 5.41% |
| 2021 | $393.60M | 74.31% |
| 2020 | $225.80M | -19.47% |
| 2019 | $280.40M | 14.59% |
| 2018 | $244.70M | 23.71% |
| 2017 | $197.80M | 11.37% |
| 2016 | $177.60M | 38.75% |
| 2015 | $128.00M | 26.36% |
| 2014 | $101.30M | -18.70% |
| 2013 | $124.60M | -9.91% |
| 2012 | $138.30M | -4.95% |
| 2011 | $145.50M | -3.06% |
| 2010 | $150.10M | 16.27% |
| 2009 | $129.10M | 38.52% |
| 2008 | $93.20M | 91.72% |
| 2007 | $48.61M | 41.23% |
| 2006 | $34.42M | 188.06% |
| 2005 | $11.95M | -344.01% |
| 2004 | $-4.90M | -37.46% |
| 2003 | $-7.83M | 89.27% |
| 2002 | $-4.14M | -168.88% |
| 2001 | $6.01M | 158.88% |
| 2000 | $2.32M | 0.00% |
รายได้ของบริษัทหรือคู่แข่งที่คล้ายกัน
| บริษัท | รายได้ | ความแตกต่างของรายได้ | ประเทศ |
|---|---|---|---|
| $7.51B | -26,829.54% |
US
|
|
| $5.56B | -19,897.15% |
IE
|
|
| $5.15B | -18,420.28% |
US
|
|
| $3.86B | -13,840.21% |
US
|
|
| - | - |
DE
|
